Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Double-blind Cross-over Trial of Dalfampridine ER for Effect on Ambulatory Activity in People With Multiple Sclerosis

NCT01356940 is registered in ClinicalTrials.gov with Brown, Theodore R., M.D., MPH as lead sponsor.

NCT NCT01356940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01356940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Double-blind Cross-over Trial of Dalfampridine ER for Effect on Ambulatory Activity in People With Multiple Sclerosis
Lead sponsor
Brown, Theodore R., M.D., MPH
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2013
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis